These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19034199)

  • 101. Fetal amino acids in normal pregnancies and in pregnancies complicated by intrauterine growth retardation.
    Cetin I; Marconi AM; Corbetta C; Lanfranchi A; Baggiani AM; Battaglia FC; Pardi G
    Early Hum Dev; 1992; 29(1-3):183-6. PubMed ID: 1396234
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Utility of Cerebroplacental Ratio in IUGR Fetuses from Pregnancy with Preeclampsia in Prediction the Risk for Perinatal Complications.
    Novac MV; Moldoveanu A; Tudorache Ş; Oprescu ND; Miescu M; Siminel MA; Vrabie S; Novac MB; Iliescu DG
    Curr Health Sci J; 2017; 43(3):231-235. PubMed ID: 30595881
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Determination of thiamine (vitamin B1) in maternal blood during normal pregnancies and pregnancies with intrauterine growth retardation.
    Heinze T; Weber W
    Z Ernahrungswiss; 1990 Mar; 29(1):39-46. PubMed ID: 2333720
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The effect of a maternal infusion of amino acids on umbilical uptake in pregnancies complicated by intrauterine growth restriction.
    Ronzoni S; Marconi AM; Paolini CL; Teng C; Pardi G; Battaglia FC
    Am J Obstet Gynecol; 2002 Sep; 187(3):741-6. PubMed ID: 12237657
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The effects of essential fatty acids preparation in the treatment of intrauterine growth retardation.
    Zhang L
    Am J Perinatol; 1997 Oct; 14(9):535-7. PubMed ID: 9394162
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Ghrelin to obestatin ratio in maternal serum in pregnancies complicated by intrauterine growth restriction.
    Xue HF; Wu WG; Yan HL; She Y; Ge HY
    Clin Exp Obstet Gynecol; 2017; 44(3):364-369. PubMed ID: 29949274
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?
    Srinivas SK; Edlow AG; Neff PM; Sammel MD; Andrela CM; Elovitz MA
    J Perinatol; 2009 Oct; 29(10):680-4. PubMed ID: 19609308
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effect of moderate, 30 percent global maternal nutrient reduction on fetal and postnatal baboon phenotype.
    Li C; Jenkins S; Mattern V; Comuzzie AG; Cox LA; Huber HF; Nathanielsz PW
    J Med Primatol; 2017 Dec; 46(6):293-303. PubMed ID: 28744866
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Laivuori H; Uotila J
    Pregnancy Hypertens; 2020 Oct; 22():7-13. PubMed ID: 32682321
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Plasma sialic acid during normal & abnormal pregnancies.
    Pant M; Raman L
    Indian J Med Res; 1983 Sep; 78():361-4. PubMed ID: 6674157
    [No Abstract]   [Full Text] [Related]  

  • 111. The fatty acid composition of placenta in intrauterine growth retardation.
    Percy P; Vilbergsson G; Percy A; Månsson JE; Wennergren M; Svennerholm L
    Biochim Biophys Acta; 1991 Jul; 1084(2):173-7. PubMed ID: 1854802
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Allo-non-specific elevation of maternal killer cell activity in intrauterine growth restriction.
    Fujii T; Tsushima R; Okai T; Shibata Y; Taketani Y
    Int J Gynaecol Obstet; 1996 Mar; 52(3):237-42. PubMed ID: 8775675
    [TBL] [Abstract][Full Text] [Related]  

  • 113. PP033. Oxidized LDL particles in the placenta of intrauterine growth restriction (IUGR) subgroups.
    Pecks U; Caspers R; Sosnowsky K; Maass N; Rath W; Huppertz B
    Pregnancy Hypertens; 2013 Apr; 3(2):78-9. PubMed ID: 26105886
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Polyphenols and IUGR Pregnancies: Effects of Maternal Hydroxytyrosol Supplementation on Hepatic Fat Accretion and Energy and Fatty Acids Profile of Fetal Tissues.
    Garcia-Contreras C; Vazquez-Gomez M; Pardo Z; Heras-Molina A; Encinas T; Torres-Rovira L; Astiz S; Nieto R; Ovilo C; Gonzalez-Bulnes A; Isabel B
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284510
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies.
    Pecks U; Rath W; Kleine-Eggebrecht N; Maass N; Voigt F; Goecke TW; Mohaupt MG; Escher G
    Geburtshilfe Frauenheilkd; 2016 Jul; 76(7):799-808. PubMed ID: 27582578
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction.
    Bar-Or D; Heyborne KD; Bar-Or R; Rael LT; Winkler JV; Navot D
    Prenat Diagn; 2005 Mar; 25(3):245-9. PubMed ID: 15791656
    [TBL] [Abstract][Full Text] [Related]  

  • 117. OS048 Mitochondrial content and function in placental cells and tissuesof preeclampsia and IUGR.
    Mando' C; Marino MA; Miriam F; Palma CD; Borelli M; Trabattoni D; Stampalija T; Ferrazzi E; Clementi E; Cetin I
    Pregnancy Hypertens; 2012 Jul; 2(3):203. PubMed ID: 26105262
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Mean Platelet Volume is Affected in Term Fetuses with Intrauterine Growth Restriction.
    Buyuk GN; Oskovi-Kaplan ZA; Oksuzoglu A; Keskin HL
    Z Geburtshilfe Neonatol; 2021 Feb; 225(1):70-73. PubMed ID: 32590873
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Effect of increased substrate availability on fatty acid synthesis in the growth retarded fetus.
    Vileisis RA; Oh W
    Metabolism; 1983 Jan; 32(1):90-4. PubMed ID: 6848902
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.